Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: implications for rheumatoid arthritis

Vasoactive intestinal peptide (VIP) is an anti-inflammatory immunomodulatory neuropeptide with therapeutic potential demonstrated for collagen-induced arthritis. The aim of this study was to characterise its potential anti-arthritic effect on human monocytes, macrophages, T cells, and rheumatoid art...

Descripción completa

Detalles Bibliográficos
Autores principales: Foey, Andrew D, Field, Sarah, Ahmed, Salman, Jain, Abhilash, Feldmann, Marc, Brennan, Fionula M, Williams, Richard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC333423/
https://www.ncbi.nlm.nih.gov/pubmed/14680506
http://dx.doi.org/10.1186/ar999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC333423/
https://www.ncbi.nlm.nih.gov/pubmed/14680506
http://dx.doi.org/10.1186/ar999

Ejemplares similares